Food effect group:Randomized crossover dosing
Sponsors
Huashan Hospital Fudan University, Peking University First Hospital
Conditions
Prevention and treatment of venous thromboembolismhyperphosphatemia
Phase 1
A phase I, randomized, double-blind, placebo-controlled, single, and multiple-dose escalation study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of JMKX003002 in healthy participants: a randomized, open-label, 3-period crossover food effect study
Active, not recruitingChiCTR2300070473
Start: 2023-04-14Updated: 2023-06-04
A phase I, randomized, double-blind, placebo-controlled, single, and multiple-dose escalation study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of JMKX001149 in healthy participants and a randomized, open-label, 2-period crossover food effect study
Active, not recruitingChiCTR2300073173
Start: 2023-07-03Updated: 2023-07-10